Lucas M - Search Results

1

Post-transplant interleukin-2 in patients with low-grade lymphoid neoplasms previously treated with fludarabine is limited by hematologic toxicity.

Waselenko JK, Burrows A, Nelson DA, Lucas M, Ekstrand J, Edenfield WJ, Myhand RC. Waselenko JK, et al. Among authors: lucas m. Ann Hematol. 2003 Sep;82(9):552-7. doi: 10.1007/s00277-003-0726-x. Epub 2003 Aug 9. Ann Hematol. 2003. PMID: 12910372 Clinical Trial.

2

A phase I/II study examining pentostatin, chlorambucil, and theophylline in patients with relapsed chronic lymphocytic leukemia and non-Hodgkin's lymphoma.

Willis CR, Goodrich A, Park K, Waselenko JK, Lucas M, Reese A, Diehl LF, Grever MR, Byrd JC, Flinn IW. Willis CR, et al. Among authors: lucas m. Ann Hematol. 2006 May;85(5):301-7. doi: 10.1007/s00277-005-0025-9. Epub 2006 Mar 4. Ann Hematol. 2006. PMID: 16518606 Clinical Trial.

3

Rituximab using a thrice weekly dosing schedule in B-cell chronic lymphocytic leukemia and small lymphocytic lymphoma demonstrates clinical activity and acceptable toxicity.

Byrd JC, Murphy T, Howard RS, Lucas MS, Goodrich A, Park K, Pearson M, Waselenko JK, Ling G, Grever MR, Grillo-Lopez AJ, Rosenberg J, Kunkel L, Flinn IW. Byrd JC, et al. Among authors: lucas ms. J Clin Oncol. 2001 Apr 15;19(8):2153-64. doi: 10.1200/JCO.2001.19.8.2153. J Clin Oncol. 2001. PMID: 11304767 Clinical Trial.

4

Rituximab therapy in Waldenstrom's macroglobulinemia: preliminary evidence of clinical activity.

Byrd JC, White CA, Link B, Lucas MS, Velasquez WS, Rosenberg J, Grillo-López AJ. Byrd JC, et al. Among authors: lucas ms. Ann Oncol. 1999 Dec;10(12):1525-7. doi: 10.1023/a:1008350208019. Ann Oncol. 1999. PMID: 10643548 Free article.

5

Phase I study of low-dose interleukin-2, fludarabine, and cyclophosphamide for previously untreated indolent lymphoma and chronic lymphocytic leukemia.

Kasamon YL, Flinn IW, Grever MR, Diehl LF, Garrett-Mayer E, Goodman SN, Lucas MS, Byrd JC. Kasamon YL, et al. Clin Cancer Res. 2005 Dec 1;11(23):8413-7. doi: 10.1158/1078-0432.CCR-05-1612. Clin Cancer Res. 2005. PMID: 16322303 Clinical Trial.

6

Antibody therapy for chronic lymphocytic leukemia: a promising new modality.

Lin TS, Moran M, Lucas M, Waymer S, Jefferson S, Fischer DB, Grever MR, Byrd JC. Lin TS, et al. Among authors: lucas m. Hematol Oncol Clin North Am. 2004 Aug;18(4):895-913, ix-x. doi: 10.1016/j.hoc.2004.04.008. Hematol Oncol Clin North Am. 2004. PMID: 15325705 Review.

7

Filgrastim and alemtuzumab (Campath-1H) for refractory chronic lymphocytic leukemia.

Lin TS, Flinn IW, Lucas MS, Porcu P, Sickler J, Moran ME, Lucas DM, Heerema NA, Grever MR, Byrd JC. Lin TS, et al. Among authors: lucas ms, lucas dm. Leukemia. 2005 Jul;19(7):1207-10. doi: 10.1038/sj.leu.2403782. Leukemia. 2005. PMID: 15858611 Clinical Trial.

8

Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia.

Rogers KA, Huang Y, Ruppert AS, Abruzzo LV, Andersen BL, Awan FT, Bhat SA, Dean A, Lucas M, Banks C, Grantier C, Heerema NA, Lozanski G, Maddocks KJ, Valentine TR, Weiss DM, Jones JA, Woyach JA, Byrd JC. Rogers KA, et al. Among authors: lucas m. J Clin Oncol. 2020 Nov 1;38(31):3626-3637. doi: 10.1200/JCO.20.00491. Epub 2020 Aug 14. J Clin Oncol. 2020. PMID: 32795224 Free PMC article. Clinical Trial.

9

A phase I/II dose escalation study of apolizumab (Hu1D10) using a stepped-up dosing schedule in patients with chronic lymphocytic leukemia and acute leukemia.

Lin TS, Stock W, Xu H, Phelps MA, Lucas MS, Guster SK, Briggs BR, Cheney C, Porcu P, Flinn IW, Grever MR, Dalton JT, Byrd JC. Lin TS, et al. Leuk Lymphoma. 2009 Dec;50(12):1958-63. doi: 10.3109/10428190903186486. Leuk Lymphoma. 2009. PMID: 19860603 Free PMC article. Clinical Trial.

10

Effects of motexafin gadolinium in a phase II trial in refractory chronic lymphocytic leukemia.

Lin TS, Naumovski L, Lecane PS, Lucas MS, Moran ME, Cheney C, Lucas DM, Phan SC, Miller RA, Byrd JC. Lin TS, et al. Among authors: lucas ms, lucas dm. Leuk Lymphoma. 2009 Dec;50(12):1977-82. doi: 10.3109/10428190903288464. Leuk Lymphoma. 2009. PMID: 19860624 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,882 results

Search Page